Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials
Conclusions: Conclusions:Antifungal prevention of systemic candidiasis in immunocompetent critically ill adults did not reduce mortality and may have decreased secondary fungal infection rates. However, significant publication bias was present.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Review Article Source Type: research
More News: Cancidas | Candida | Caspofungin | Clinical Trials | Conferences | Fluconazole | Fungal Infections | Ketoconazole | Study